French-German biotech SMEY launches Lipid Atlas, an AI-powered platform designed to accelerate lipidomics research, biomarker discovery and precision medicine.

As flashy apps plateau, the most valuable travel tech in 2026 will live deep in infrastructure, data and connectivity—far from the customer-facing interface.

Anti Fund, co-founded by Jake Paul, is pitching a new venture model built on attention, disciplined execution and long-term trust, not celebrity hype.